Search Results - Christof Scheid
- Showing 1 - 8 results of 8
-
1
Early detection of multiple myeloma: A first step towards a screening programme Autoría: Christof Scheid, Ola Landgren
Published 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Long‐term remission in a patient with relapsed Richter's transformation treated with CD19‐directed chimeric antigen‐receptor T‐cells after allogeneic stem cell transplantation... Autoría: Nadine Kutsch, Philipp Gödel, Conrad‐Amadeus Voltin, Michael Hallek, Christof Scheid, Peter Borchmann, Udo Holtick
Published 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
3
Post‐transplant‐cyclophosphamide and short‐term Everolimus as graft‐versus‐host‐prophylaxis in patients with relapsed/refractory lymphoma and myeloma—Final results of the phase II... Autoría: Tim Richardson, Christof Scheid, Marco Herling, Lukas P. Frenzel, Carmen Herling, Marta Rebecca Cruz Aguilar, Sebastian Theurich, Michael Hallek, Udo Holtick
Published 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
4
European Recommendations for Transitioning the Care of Patients With Multiple Myeloma Treated With B‐Cell Maturation Antigen Bispecific Antibodies From Academic Hospitals to Commun... Autoría: María‐Victoria Mateos, Elena Zamagni, Massimo Gentile, Rachel Hall, Florence Lachenal, Mónica López Riñon, Rakesh Popat, Christof Scheid, Thomas Wolff, Isabel Perez‐Cruz, Mohamad Mohty
Published 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
5
Early Free Light‐Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA‐Directed CAR‐T Cells Autoría: Tim Richardson, Hishan Tharmaseelan, Guido Kobbe, Ben‐Niklas Baermann, Tobias A. W. Holderried, Friederike Schmitz, Martina Crysandt, Philipp Gödel, Nathan Wolfensberger, Daniel Schütte, Michael Hallek, Christof Scheid, Udo Holtick
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
6
Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG ‐ MM5 Trial Autoría: Tim Richardson, Elias Mai, Ekaterina Menis, Axel Benner, Diana Tichy, Kaya Miah, Mathias Hänel, Britta Besemer, Amelie Boquoi, Igor Wolfgang Blau, Christian S. Michel, Hans Walter Lindemann, Snjezana Janjetovic, Peter Brossart, Helga Bernhard, Peter Reimer, Hans Salwender, Dirk Hose, Anja Seckinger, Marc Raab, Hartmut Goldschmidt, Christof Scheid
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
7
Operational burden and fragmented implementation in CAR T‐cell therapy: Insights from a multinational survey by the GoCART Coalition and the JACIE Quality Managers Committee Autoría: Nick van Sinderen, Julie Dolva, Caterina Riillo, Raquel Espada, Christof Scheid, Suzanne van Dorp, Marten Nijziel, Margot Jak, Florent Malard, Christian Chabannon, Andrea Egan, Chiara Bonini, Julio Delgado, Martin Dreyling, Annalisa Ruggeri, Marion Subklewe, Anna Sureda, Yolanda Cabrerizo, Ibrahim Yakoub‐Agha, Tuula Rintala, Lynn Manson, Laurel Anderson, Olivier Urbain, Rachel Luke, Lea Brandt Kristensen, Anne Emmett, Jürgen Kuball
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
8
Autologous stem cell transplantation in NK/T‐cell lymphoma: Prognostic impact of EBV‐DNA in a multinational cohort—A study by the EBMT Lymphoma Working Party Autoría: Philipp Berning, Maud Ngoya, Won Seog Kim, Evgenii Shumilov, Depei Wu, Haiwen Huang, Anne Cairoli, Alessandra Tucci, Guillaume Dachy, Romain Gounot, Anne C. Wilke, Christof Scheid, Peter Dreger, Jose Luis Lopez Lorenzo, Adrian Bloor, Joanna Romejko‐Jarosinska, Alain Gadisseur, Roland Schroers, Péter Reményi, Ludovic Gabellier, Monica Poiani, Khalid Halahleh, Jacques‐Emmanuel Galimard, Georg Lenz, Anna Sureda, Ali Bazarbachi, Bertram Glass, Norbert Schmitz
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso